A synthetic analog of alpha-melanocyte-stimulating hormone that stimulates melanogenesis, increasing skin pigmentation and providing photoprotection against UV radiation.
Dawson. B V BV; Hadley. M E ME; Levine. N N; Kreutzfeld. K L KL; Don. S S; Eytan. T T; Hruby. V J VJ
Scientists showed that a powerful melanin‑stimulating peptide can pass through human skin samples in a lab setting, staying intact and still active. The amount that gets through depends on where on the skin it’s applied and how thick the skin layer is. This is the first lab proof that a melanotropic peptide could be delivered topically, hinting at future skin‑tanning or pigment‑restoring creams, but it’s far from a ready‑to‑use protocol for DIY users.
Colombo. G G; Sordi. A A; Turcatti. F F; Carlin. A A; Rossi. C C; Lonati. C C; Santambrogio. L L; Ga...
A lab study found that a synthetic version of the hormone alpha‑MSH can slow the growth of a cancer cell line by turning off key genes that drive cell division and inflammation, but this was only tested in petri dishes, not in people.
The study shows that the skin hormone alpha‑MSH (the basis of melanotan‑I) can boost a protective protein called p16 after mild UV exposure, which might help the skin’s natural defense against cancer, but the research is early and doesn’t give any dosing advice.
The study shows that the melanocortin‑1 receptor (the target of melanotan‑I) is located on the outer membrane of a human melanoma cell line, confirming the receptor is accessible for binding. This is basic cell‑biology work and doesn’t give dosing or safety tips for everyday use.
In rats, a single injection of melanotan‑I (NDP‑MSH) before removing 70% of the liver changed many gene messages, boosted an inflammation‑related IL‑6/STAT signaling pathway, and lessened the drop of a protein called IκBα, but it didn’t noticeably speed up the liver’s overall regrowth.
Daynes. R A RA; Robertson. B A BA; Cho. B H BH; Burnham. D K DK; Newton. R R
In mice, the peptide alpha‑melanocyte‑stimulating hormone (the same molecule behind melanotan‑I) can block some of the body’s fever‑and‑immune responses triggered by the inflammatory signal IL‑1, but it doesn’t stop all of them. A stronger lab‑made version works even better, yet neither form changes certain other inflammation markers. This shows the peptide has selective anti‑inflammatory effects in animals, but we don’t know if it works the same way in people.
Morozova. L F LF; D'iakov. V L VL; Sukhanov. V A VA
The study shows that a synthetic version of alpha‑MSH (the same type of peptide used in melanotan‑I) can make some melanoma cells grow faster while slowing down others, and it doesn’t affect normal lung cells. This means the peptide isn’t uniformly safe or harmful for skin cancer cells, and the effect depends on the cell’s melanin type.
The study shows that a natural fragment of ACTH (ACTH1-17) sticks to the skin‑color receptor (MC1R) almost as well as the usual hormone alpha‑MSH, but it triggers the cell’s signaling pathways even more strongly, leading to more pigment production. This suggests ACTH1-17 is a very potent MC1R activator, potentially stronger than the synthetic peptide melanotan‑I that many hobbyists use for tanning.
In mice, the hormone alpha‑melanocyte‑stimulating hormone (the basis of melanotan‑I) can blunt inflammation‑driven fever, blood‑cell spikes, and some immune protein changes caused by the inflammatory signals IL‑1 and TNF. The effect works both when the peptide is given under the skin and when tiny amounts are injected directly into the brain, showing a link between the nervous system and immune response. However, the study used mouse models and direct injections, not the ways people would normally take melanotan‑I, so the findings aren’t ready to be turned into a home protocol.
Scientists looked at 11 genetic variants of the MC4R receptor that are linked to severe childhood obesity. They found that some variants can't bind the hormone (or drug) well and don't trigger the usual cell signals, while other variants work just like the normal receptor. This shows that not all MC4R mutations cause functional problems.
Haskell-Luevano. C C; Cone. R D RD; Monck. E K EK; Wan. Y P YP
Scientists changed specific parts of the mouse melanocortin‑4 receptor to see how it interacts with different melanocortin peptides, including the popular research peptide MTII (melanotan‑II). They identified several receptor spots that are crucial for the peptide to bind and work, and showed how tiny changes in the peptide’s shape affect its activity.
Rinne. Petteri P; Penttinen. Anna-Maija AM; Nordlund. Wendy W; Ahotupa. Markku M; Savontaus. Eriika...
In mice that develop high blood pressure from a salty diet, a stable version of the hormone α‑MSH (called NDP‑α‑MSH) made them pee out more water and salt, which kept their blood pressure from rising. The effect only showed up in the hypertensive mice, not in normal mice, and it didn’t change markers of oxidative stress.
Benelli. A A; Zanoli. P P; Botticelli. A A; Bertolini. A A
In a rat study, a synthetic version of the melanotan-I peptide called [Nle4,D-Phe7]alpha-MSH helped the animals recover better after a brain injury. The treated rats moved less in a rotation test and performed better on sensorimotor tasks. The peptide also reduced the size of the brain lesion and seemed to promote supportive brain cell growth.
Florijn. W J WJ; Holtmaat. A J AJ; de Lang. H H; Spierenburg. H H; Gispen. W H WH; Versteeg. D H DH
In rats, giving a brain‑injected form of ACTH or a synthetic alpha‑MSH drug caused the animals to groom a lot and raised dopamine levels in a brain area called the caudate nucleus. The effect was linked to the peptide’s ability to activate the alpha‑melanocyte stimulating hormone receptor, but the same effect wasn’t seen with a shorter ACTH fragment. Tolerance built up to the grooming behavior after one dose, but not to the dopamine rise.
Scientists cloned the MC4R gene from a fish and studied how it reacts to several melanocortin‑related peptides, including the tanning peptide α‑MSH. The fish receptor works similarly to human MC4R but shows some differences in how strongly it binds these compounds. The work is basic research and doesn’t give any direct tips for using melanotan‑I in people.
Hoch. Matthias M; Hirzel. Estelle E; Lindinger. Peter P; Eberle. Alex N AN; Linscheid. Philippe P; M...
The study shows that activating the MC1‑R receptor in human fat cells with a strong melanotan‑I‑like drug barely triggers internal signals and doesn’t boost fat breakdown or change inflammation markers, though it can slow the growth of early‑stage stem cells.
Joseph. Christine G CG; Yao. Hua H; Scott. Joseph W JW; Sorensen. Nicholas B NB; Marnane. Rebecca N...
The study shows that tiny changes to the peptide melanotan‑I (γ2‑MSH) affect how it works on mouse receptors, and that mouse and human receptors respond differently, with mouse MC5R being more sensitive. It also found that giving a related peptide (NDP‑MSH) by injection in mice lowers brain levels of certain melanocortin receptors. These findings are mostly about basic biology in mice, not direct human use.
The study shows that the MC4R protein, which melanotan‑i targets, can stick together in pairs or larger groups, and that its connection to a G‑protein changes how these groups form and work. This is mostly basic science and doesn’t give direct advice on how to use the peptide.
Yang. Yingkui Y; Mishra. Vinod K VK; Chen. Min M; Duffee. Elaine E; Dimmitt. Reed R; Harmon. Carroll...
The study mapped which parts of the human MC5R protein are important for binding the peptide NDP‑α‑MSH, a close relative of melanotan‑I, by swapping out specific amino acids and seeing how binding and signaling changed. It’s a basic science look at receptor structure, not a guide on how to use melanotan‑I in humans.
Todorovic. Aleksandar A; Ericson. Mark D MD; Palusak. Ryan D RD; Sorensen. Nicholas B NB; Wood. Mich...
The study swapped individual building blocks (alanine) into two related skin‑pigment peptides—natural α‑MSH and the synthetic, stronger NDP‑MSH—to see how each change affects activity at mouse receptors. It found that some swaps dramatically reduced activity, but the effects weren’t the same for the two peptides, meaning you can’t assume what works for one will work for the other.